DaVita Inc.

NYSE:DVA

Medical - Care Facilities

Healthcare
$161.79 +0.77%

+$1.60 today

Market cap
$10.18B
Beta
0.91
P/E (TTM)
18.2
EPS (TTM)
$11.60
52W Low $101.00High $213.44

Volume 1.12M

Average 0.84M

DVA Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

DaVita Inc.NYSE: DVA

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables turns positive

Q2 FY2026 accounts payables was $31.41M, compared with -$10.58M a year earlier. Trailing-twelve-month accounts payables was $100.33M. Over 3 fiscal years it compounded at +13.6% a year.

Context

  • Accounts payables amounted to 0.9% of revenue in FY2025, up 0.9 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near $31.41M or moves back toward the trailing-twelve-month quarterly average of $25.08M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$31.41M+232.1% QoQ
Last fiscal yearDec 2025
$128.3M+7451.7% YoY
LTMJun 2026
$100.33M+31.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+396.8%——
1 year+7451.7%——
3-year CAGR+13.6%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
128.3M USD
Year-over-year change
+7451.7%

Accounts Payables vs competitors

How DVA compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +31.5% is the highest of 3, against a peer median of -76.3%.
  • Accounts payables amounts to 0.7% of revenue for DVA, versus a peer median of 0.3%.
DVA Competitors
Accounts Payables for DVA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DVADaVita Inc.LTM Jun 2026$100.33M USD+31.5%+13.6%0.7%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€46.03M EUR-75.8%-65.9%0.2%
BAXBaxter International Inc.LTM Jun 2026$32M USD-76.8%—0.3%
Peer median (excluding DVA) —-76.3%-65.9%0.3%

Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.21B781.64M691.54M1.25B1.08B
Depreciation & Amortization680.62M732.6M745.44M723.86M715.35M
Deferred Income Tax60.48M(75.67M)(39.35M)(57.84M)86.57M
Stock-Based Compensation102.21M95.43M112.38M102.79M139.95M
Change in Working Capital(140.64M)101K194.54M(29.82M)(263.24M)
Accounts Receivables(138.14M)(148.39M)172.36M(29.77M)(210.63M)
Inventory5.72M(757K)(32.13M)17.94M(19.95M)
Accounts Payables(30.32M)87.48M26.89M1.7M128.3M
Other Working Capital22.1M61.77M27.42M(19.7M)(160.96M)
Other Non-Cash Items16.45M30.47M354.5M32.31M129.15M
Operating Cash Flow1.93B1.56B2.06B2.02B1.89B
Capital Expenditures(641.47M)(603.43M)(567.99M)(555.44M)(575.86M)
Acquisitions (Net)(200.97M)(89.19M)(26.39M)(251.27M)(144.5M)
Purchases of Investments(33.84M)(133.39M)(322.95M)(24.46M)(22.44M)
Sales of Investments27.88M74.91M110M27.2M52.14M
Other Investing Activities63.66M120.76M35.52M32.54M35.71M
Investing Cash Flow(784.73M)(630.35M)(771.8M)(771.43M)(654.95M)
Debt Repayment754.26M(11.28M)(552.62M)1.11B769.62M
Common Stock Issued018.58M16.9M20.45M23.29M
Common Stock Repurchased(1.6B)(802.23M)(272.22M)(1.39B)(1.79B)
Dividends Paid00000
Other Financing Activities(238.59M)(326.2M)(362.56M)(560.56M)(374.69M)
Financing Cash Flow(1.08B)(1.12B)(1.17B)(816.94M)(1.37B)
Effect of Forex Changes(10.01M)(29.07M)8.91M(18.48M)21.15M
Net Change in Cash53.17M(215.97M)125.65M415.19M(122.08M)
Free Cash Flow1.29B961.14M1.49B1.47B1.31B

DaVita Inc.

NYSE:DVA

Intrinsic Alpha fair value

Locked

Current Price

$161.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.